Linde Reports Full-Year and Fourth-Quarter 2023 Results
Full-Year Highlights Sales $32.9 billion, down 2%, underlying sales up 5% Operating profit $8.0 billion; adjusted oper…
Full-Year Highlights Sales $32.9 billion, down 2%, underlying sales up 5% Operating profit $8.0 billion; adjusted oper…
Sales $8.8 billion, up 15% versus prior-year quarter Operating profit $1.6 billion; adjusted operating profit $2.0 billi…
Linde (NYSE:LIN; FWB:LIN) today announced it has signed another long-term agreement with a major space launch company in…
Sales $7.7 billion, up 12% versus prior-year quarter Operating profit $1.3 billion; adjusted operating profit $1.8 billi…
Financial Highlights Sales $7.6 billion, up 19% versus prior-year quarter Operating profit $1.1 billion; adjusted oper…
Full-Year Highlights Sales $27.2 billion, down 3% Operating profit $3.3 billion, adjusted operating profit $5.8 billio…
. Financial Highlights Operating profit margin 14.1%; adjusted operating profit margin 22.1%, up 230 basis points ve…
Linde (NYSE:LIN; FWB:LIN), a leading global supplier of inhaled nitric oxide, is pleased with the decision by the U.S. S…
Lincare, a subsidiary of Linde (NYSE:LIN; FWB:LIN), the leading provider of home respiratory care in the U.S., stands as…
Linde (NYSE: LIN; FWB: LIN) announced today it has started up a new Air Separation Unit (ASU) effectively doubling the p…